CVS Caremark
Woonsocket · Founded 1993
About CVS Caremark
CVS Caremark, a subsidiary of CVS Health, is one of the nation’s largest pharmacy benefit management (PBM) companies. It provides scalable, data-driven PBM solutions that help employers, health plans, and government partners control prescription drug costs, improve performance, and enhance medication adherence. As a company always looking to innovate, CVS Caremark is investing $100M+ to build and expand interoperability capabilities, help address costly and complex conditions, manage rising drug costs, increase transparency, improve safety and change consumer expectations for accessing care. CVS Caremark is supported by a nationwide network of more than 9,000+ CVS Pharmacy and specialty health care locations. With additional options including mail delivery and home pharmacy services, CVS Caremark works to ensure convenient and accessible medication support for its members. CVS Caremark leads the industry with its innovative TrueCost pricing model, the market’s first acquisition-based, drug-level net cost pricing model. It eliminates cross-subsidization to better demonstrate our purchasing power for all medications. This pricing model is more transparent for clients, more predictable for members and more viable for pharmacies. Headquartered in Woonsocket, Rhode Island, CVS Caremark's clients are primarily entities that sponsor health benefit plans, such as large employers, health insurance companies, unions, and government agencies. These clients work with Caremark to manage the prescription drug benefits for their members and employees.
Company Facts
- Founded: 1993
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 10,001+
- Estimated revenue: $10K – $50K
- Funding stage: M&A
- Website: http://www.caremark.com
- Phone: 1 (800) 552-8159
Social Profiles
Canonical: https://fsome.com/organization/cvs-caremark-2225862 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.